OncBioMune Pharmaceuticals Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • OncBioMune Pharmaceuticals's estimated annual revenue is currently $1.1M per year.(i)
  • OncBioMune Pharmaceuticals's estimated revenue per employee is $155,000

Employee Data

  • OncBioMune Pharmaceuticals has 7 Employees.(i)
  • OncBioMune Pharmaceuticals grew their employee count by 0% last year.

OncBioMune Pharmaceuticals's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4M2618%N/AN/A
#2
$1.4M814%N/AN/A
#3
$6.4M41-24%N/AN/A
#4
$2.5M1623%N/AN/A
#5
$3.3M2140%N/AN/A
#6
$2.5M11-15%N/AN/A
#7
$0.8M40%N/AN/A
#8
$0.9M860%N/AN/A
#9
$6.4M18-44%N/AN/A
#10
$0.3M30%N/AN/A
Add Company

What Is OncBioMune Pharmaceuticals?

OncBioMune Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a proprietary Vaccine Technology that is designed to stimulate the immune system to attack its own cancer while not hurting the patient. Our lead product, ProscaVax(r) is scheduled to commence a Phase 2 clinical study in early 2016. OncBioMune also has a portfolio of targeted therapies, some of which are biosimilars to blockbuster drugs. OncBioMune is headquartered in Baton Rouge, LA.

keywords:N/A

N/A

Total Funding

7

Number of Employees

$1.1M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.5M717%N/A
#2
$0.5M70%N/A
#3
$1.4M7-36%N/A
#4
N/A7-22%N/A
#5
$0.1M70%$3.1M